S&P 5007,713▲ 0.28%Nasdaq26,425▼ 0.02%Dow Jones52,496▲ 1.02%Nasdaq 10029,490▼ 0.13%VIX17.31▼ 6.13%US Dollar101.73▼ 0.25%Gold spot4,145▲ 0.30%WTI spot101.91▲ 1.04%
Home › PNR › Research report
← PNR page
XStocksXray
Market X-Ray report · 20 October 2026

Pantoro Gold Ltd (PNR)

Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026

Key indicators

Last closeAUD 2.830
52-week range1.715 – 5.980
Return, 1 month / 3 months−1.4% / +32.9%
Return, 1 year / 3 years−49.6% / +287.1%
TrendBelow its 200-day average
RSI (14)49
Volatility (1 year)71.5%
Worst drawdown (1 year)-67.5%
Average daily value traded10.03M AUD
Dividend yield–

Market X-Ray price-based

51/ 100 · High confidence · ahead of 51% of stocks on this exchange
Trend38
Momentum51
Stability (higher is calmer)40
Liquidity92
Income–

Five-year price chart navy: price · brown: 200-day average

0.111.973.835.687.542021-102023-012024-042025-072026-10

About the company

Pantoro Gold is an Australian gold mining company that explores for and produces gold. Its main operations centre on the Norseman project in Western Australia, where it mines and processes ore to produce gold doré. The company also holds exploration ground in other parts of Western Australia. Its customers are the refiners and bullion markets that take gold from mine sites, and it is based in Australia.

The shares are listed on the Australian Securities Exchange in Australia under the code PNR, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Pantoro Gold Ltd (PNR) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.830 on 20 October 2026.

Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 896 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 49.6% and over the last three months it rose 32.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Pantoro Gold Ltd (PNR)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend38 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-16.0%
From 52-week high-52.0%
Momentum51 · FairTypical recent returns for this exchange.
3-month return32.9%
6-month return-24.9%
12-month return, skipping the last month-48.9%
Stability (higher is calmer)40 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)71.5%
Worst drawdown, 1 year (smaller is calmer)-67.5%
Liquidity92 · StrongTrades actively.
Average daily value traded10.03M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−1.4%
1 month−1.4%
3 months+32.9%
6 months−24.9%
1 year−49.6%
3 years+287.1%
5 years–

Signals

50-day / 200-day average2.768 / 3.371
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.150

Technical summary

DailyBearish5 bullish · 3 neutral · 8 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026